Clinical Trial Update: iConquerFear Program for the Treatment of Fear of Cancer Recurrence in Patients With Localized Renal Cell Carcinoma

View source ↗

Summary

The iConquerFear program for Fear of Cancer Recurrence in patients with localized renal cell carcinoma has been withdrawn from the clinical trial.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Snippet

Sponsor: City of Hope Medical Center | Conditions: Renal Cell Carcinoma | Status: WITHDRAWN